Literature DB >> 23314673

Hypoxia biomarkers, oxidative stress, and circulating microparticles in pediatric patients with thalassemia in Upper Egypt.

Khalid I Elsayh1, Asmaa M Zahran2, Taghrid B El-Abaseri3, Amany O Mohamed4, Tarek H El-Metwally4.   

Abstract

This study aimed to investigate the oxidative stress, hypoxia biomarkers, and circulating microparticles (MPs) in β thalassemia major. The study included 56 children with thalassemia and 46 healthy controls. Hypoxia biomarkers, oxidative stress biomarkers, and total plasma fragmented DNA (fDNA) were detected by the standard methods. The MPs were assessed by flow cytometry. Hypoxia and oxidative stress biomarkers, fDNA, and MPs were higher and total antioxidant capacity (TAC) was lower in patients with thalassemia than the controls. In splenectomized patients and those who had complications, vascular endothelial growth factor (VEGF), malondialdehyde, fDNA, endothelial, platelet, and activated platelet MP levels were higher while, TAC was lower than the nonsplenectomized patients. In conclusion, the increased tissue hypoxia, oxidative stress in β thalassemia, and its relationship with DNA damage and MPs release could explain many complications of thalassemia and may have therapeutic implications. The VEGF could serve as an important indicator for adequacy of blood transfusion in thalassemia.
© The Author(s) 2013.

Entities:  

Keywords:  circulating microparticles; fragmented DNA; hypoxia; oxidative stress; β thalassemia major

Mesh:

Substances:

Year:  2013        PMID: 23314673     DOI: 10.1177/1076029612472552

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

1.  Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients.

Authors:  Panjaree Siwaponanan; Suthat Fucharoen; Pornpan Sirankapracha; Pranee Winichagoon; Tsukuru Umemura; Saovaros Svasti
Journal:  Int J Hematol       Date:  2016-06-06       Impact factor: 2.490

2.  Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients.

Authors:  Janejira Kittivorapart; Vanja Karamatic Crew; Marieangela C Wilson; Kate J Heesom; Noppadol Siritanaratkul; Ashley M Toye
Journal:  Blood Adv       Date:  2018-01-23

3.  β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals.

Authors:  Syed Ghulam Musharraf; Ayesha Iqbal; Saqib Hussain Ansari; Sadia Parveen; Ishtiaq Ahmad Khan; Amna Jabbar Siddiqui
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

4.  Extracellular Vesicle Characteristics in β-thalassemia as Potential Biomarkers for Spleen Functional Status and Ineffective Erythropoiesis.

Authors:  Carina Levin; Ariel Koren; Annie Rebibo-Sabbah; Naama Koifman; Benjamin Brenner; Anat Aharon
Journal:  Front Physiol       Date:  2018-08-30       Impact factor: 4.566

5.  Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis.

Authors:  Yasushi Matsukiyo; Hidenari Nagai; Teppei Matsui; Yoshinori Igarashi
Journal:  J Immunol Res       Date:  2018-07-15       Impact factor: 4.818

6.  Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients.

Authors:  Hanaa Abd El-Samee; Noha Bassiouny; Nermeen Nabih
Journal:  Hematol Rep       Date:  2020-11-17

7.  Cardiorespiratory and metabolic fitness indicators in novice volleyball trainees: effect of 1-week antioxidant supplementation with N-acetyl-cysteine/zinc/vitamin C.

Authors:  Abdulrahman A Alduraywish
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

8.  Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use.

Authors:  Saeid Mezail Mawazi; Sinan Mohammed Abdullah Al-Mahmood; Bappaditya Chatterjee; Hazrina Ab Hadi; Abd Almonem Doolaanea
Journal:  Pharmaceutics       Date:  2019-09-20       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.